Peapack-Gladstone Financial Corp’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q2 | – | Sell |
-1,791
| Closed | -$249K | – | 326 |
|
2016
Q1 | $249K | Sell |
1,791
-150
| -8% | -$20.9K | 0.02% | 286 |
|
2015
Q4 | $370K | Sell |
1,941
-28
| -1% | -$5.34K | 0.03% | 237 |
|
2015
Q3 | $308K | Hold |
1,969
| – | – | 0.02% | 258 |
|
2015
Q2 | $356K | Sell |
1,969
-70
| -3% | -$12.7K | 0.02% | 247 |
|
2015
Q1 | $353K | Buy |
2,039
+416
| +26% | +$72.1K | 0.02% | 256 |
|
2014
Q4 | $300K | Buy |
1,623
+42
| +3% | +$7.77K | 0.02% | 260 |
|
2014
Q3 | $262K | Buy |
1,581
+90
| +6% | +$14.9K | 0.02% | 261 |
|
2014
Q2 | $233K | Sell |
1,491
-361
| -19% | -$56.4K | 0.02% | 276 |
|
2014
Q1 | $282K | Sell |
1,852
-321
| -15% | -$48.8K | 0.02% | 252 |
|
2013
Q4 | $289K | Sell |
2,173
-1,210
| -36% | -$161K | 0.02% | 243 |
|
2013
Q3 | $393K | Hold |
3,383
| – | – | 0.03% | 211 |
|
2013
Q2 | $312K | Buy |
+3,383
| New | +$312K | 0.03% | 230 |
|